KV Pharmaceutical Signs Second International Licensing Agreement

KV Pharmaceutical Company has concluded an exclusive licensing agreement with Sigma Pharma Ltda., a division of EMS S/A, to market KV's single-dose prescription cream treatment for bacterial vaginosis (BV) in Brazil. The product is currently marketed in the U.S. by KV's Ther-Rx Corporation subsidiary under the brand name Clindesse (clindamycin phosphate) Vaginal Cream, 2 percent.

Big News Network (http://feeds.bignewsnetwork.com/redir.php?jid=e3d560ca4aeebd72&cat=6dcd932030878143)